Combined central retinal artery and vein occlusion shortly after mRNA-SARS-CoV-2 vaccination.

Ikegami, Y; Numaga, J; Okano, N; Fukuda, S; Yamamoto, H; Terada, Y

Ikegami, Y; Numaga, J; Okano, N; Fukuda, S; Yamamoto, H; Terada, Y.

Afiliación

Ikegami Y; From the Department of Ophthalmology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi District, Tokyo 173-0015, Japan.
Numaga J; From the Department of Ophthalmology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi District, Tokyo 173-0015, Japan.
Okano N; From the Department of Ophthalmology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi District, Tokyo 173-0015, Japan.
Fukuda S; From the Department of Ophthalmology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi District, Tokyo 173-0015, Japan.
Yamamoto H; From the Department of Ophthalmology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi District, Tokyo 173-0015, Japan.
Terada Y; From the Department of Ophthalmology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi District, Tokyo 173-0015, Japan.

QJM ; 114(12): 884-885, 2022 01 09.

Article en En | MEDLINE | ID: mdl-34791479

Asunto(s)

COVID-19; Oclusión de la Arteria Retiniana; Arteria Retiniana; Oclusión de la Vena Retiniana; Vacunas contra la COVID-19; Angiografía con Fluoresceína; Humanos; ARN Mensajero; SARS-CoV-2; Vacunación/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Arteria Retiniana / Oclusión de la Vena Retiniana / Oclusión de la Arteria Retiniana / COVID-19 Límite: Humans Idioma: En Revista: QJM Asunto de la revista: MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google